Skip to main content

Advertisement

SpringerLink
Log in

Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions

  • Coronary Heart Disease (S. Virani and S. Naderi, Section Editors)
  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

A Correction to this article was published on 19 June 2018

This article has been updated

Abstract

Purpose

Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide, necessitating major efforts in prevention. This review summarizes the currently available training opportunities in CVD prevention for fellows-in-training (FITs) and residents. We also highlight the challenges and future directions for CVD prevention as a field and propose a structure for an inclusive CVD prevention training program.

Recent Findings

At present, there is a lack of centralized training resources for FITs and residents interested in pursuing a career in CVD prevention. Training in CVD prevention is not an accredited subspecialty fellowship by the American Council of Graduate Medical Education (ACGME). Although there are several independent training programs under the broad umbrella of CVD prevention focusing on different aspects of prevention, there is no unified curriculum or training.

Summary

More collaborative efforts are needed to identify CVD prevention as an ACGME-accredited subspecialty fellowship. Providing more resources can encourage and produce more leaders in this essential field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 19 June 2018

    The original version of this article contains errors in Table 3. “At least 1 project/publication in the year” and “> 1 publication per year” have been switched under the titles of “Clinical Track” and “Physician-Scientist track”.

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med. 2008;358:661–3.

    Article  PubMed  CAS  Google Scholar 

  3. Nambi V, Liu X, Chambless LE, de Lemos JA, Virani SS, Agarwal S, et al. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk—the atherosclerosis risk in communities study. Clin Chem. 2013;59:1802–10.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Pokharel Y, Gosch K, Nambi V, Chan PS, Kosiborod M, Oetgen WJ, et al. Practice-level variation in statin use among patients with diabetes: insights from the PINNACLE registry. J Am Coll Cardiol. 2016;68:1368–9.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Onorato A, Sturm AC. Heterozygous familial hypercholesterolemia. Circulation. 2016;133:e587–9.

    Article  PubMed  Google Scholar 

  6. Fernandez-Friera L, Fuster V, Lopez-Melgar B, et al. Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. J Am Coll Cardiol. 2017;70:2979–91.

    Article  PubMed  CAS  Google Scholar 

  7. Nambi V, Bhatt DL. Primary prevention of atherosclerosis: time to take a selfie? J Am Coll Cardiol. 2017;70:2992–4.

    Article  PubMed  Google Scholar 

  8. •• Shapiro MD, Fazio S. Setting the agenda for preventive cardiology. Circ Res. 2017;121:211–3. A comprehensive paper which described an potential preventive cardiology service for practical purposes and preventive cardiology training outline.

    Article  PubMed  CAS  Google Scholar 

  9. Pack QR, Keteyian SJ, McBride PE, Weaver WD, Kim HE. Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines. Am J Cardiol. 2012;110:124–8.

    Article  PubMed  Google Scholar 

  10. •• Smith SC Jr, Bittner V, Gaziano JM, et al. COCATS 4 task force 2: training in preventive cardiovascular medicine. J Am Coll Cardiol. 2015;65:1754–62. An important document published by the American College of Cardiology on the requirements for trainees for achieving milestones in cardiovascular disease prevention during their general cardiovascular disease fellowship training.

    Article  PubMed  Google Scholar 

  11. Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report. J Clin Lipidol. 2015;9:129–69.

    Article  PubMed  Google Scholar 

  12. Lloyd-Jones DM, Morris PB, Ballantyne CM, et al. ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2016;68:92–125.

    Article  PubMed  Google Scholar 

  13. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract. 2017;23:1–87.

    Article  PubMed  Google Scholar 

  14. Pack QR, Keteyian SJ, McBride PE. Subspecialty training in preventive cardiology: the current status and discoverable fellowship programs. Clin Cardiol. 2012;35:286–90.

    Article  PubMed  Google Scholar 

  15. NHLBI. National Heart Lung and blood institute, National Research Service Award Programs in cardiovascular epidemiology, biostatistics, and Prev Med 2017.

Download references

Author information

Authors and Affiliations

  1. Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Anum Saeed, Salim S. Virani, Christie M. Ballantyne & Vijay Nambi

  2. Center for Cardiometabolic Disease Prevention, Baylor College of Medicine, Houston, TX, USA

    Anum Saeed, Salim S. Virani, Peter H. Jones, Christie M. Ballantyne & Vijay Nambi

  3. Division of Cardiology, Department of Medicine, Alpert Medical School of Brown University, Providence, RI, USA

    Kaustubh Dabhadkar

  4. Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA

    Salim S. Virani & Vijay Nambi

  5. Health Policy, Quality and Informatics Program, Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development Center for Innovations, Houston, TX, USA

    Salim S. Virani

  6. The Aga Khan University, Karachi, Pakistan

    Salim S. Virani

  7. Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Christie M. Ballantyne

  8. 6655 Travis Street, Suite 320, Houston, TX, 77030, USA

    Vijay Nambi

Authors
  1. Anum Saeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaustubh Dabhadkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salim S. Virani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter H. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christie M. Ballantyne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Vijay Nambi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vijay Nambi.

Ethics declarations

Conflict of Interest

Anum Saeed and Kaustubh Dabhadkar declare no conflict of interest. Salim S. Virani receives an honorarium from the American College of Cardiology as Associate Editor for Innovations for ACC.org. Peter H. Jones has been a scientific consultant to Amgen and to Sanofi/Regeneron the past 12 months. Vijay Nambi was on a regional advisory board for Sanofi and is named on provisional patent no. 61721475 entitled “Biomarkers to Improve Prediction of Heart Failure Risk” filed by Baylor College of Medicine and Roche. Christie M. Ballantyne has received grant/research support (all paid to institution, not individual) from Abbott Diagnostic, Amarin, Amgen, Eli Lilly, Esperion, Ionis, Novartis, Pfizer, Regeneron, Roche Diagnostic, Sanofi-Synthelabo, NIH, AHA, and ADA; has been a consultant for Abbott Diagnostics, Amarin, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Esperion, Ionis, Matinas BioPharma Inc., Merck, Novartis, Pfizer, Regeneron, Roche Diagnostic, and Sanofi-Synthelabo; and is named on provisional patent no. 61721475 entitled “Biomarkers to Improve Prediction of Heart Failure Risk” filed by Baylor College of Medicine and Roche.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Coronary Heart Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saeed, A., Dabhadkar, K., Virani, S.S. et al. Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions. Curr Atheroscler Rep 20, 35 (2018). https://doi.org/10.1007/s11883-018-0735-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11883-018-0735-9

Keywords

Search

Navigation